|LETTER TO THE EDITOR
|Year : 2021 | Volume
| Issue : 3 | Page : 354-356
Role for positron emission tomography-computed tomography in melioidosis
Irfan Ismail Ayub1, Dhanasekar Thangaswamy1, Vidya Krishna2, Kopula Sathyamoorthy Sridharan3
1 Department of Pulmonary Medicine, Sri Ramachandra Medical College and Research Institute, SRIHER, Chennai, Tamil Nadu, India
2 Department of Infectious Diseases, Sri Ramachandra Medical College and Research Institute, SRIHER, Chennai, Tamil Nadu, India
3 Department of Microbiology, Sri Ramachandra Medical College and Research Institute, SRIHER, Chennai, Tamil Nadu, India
|Date of Submission||02-Dec-2020|
|Date of Acceptance||29-May-2021|
|Date of Web Publication||23-Sep-2021|
Prof. Irfan Ismail Ayub
Department of Pulmonary Medicine, Sri Ramachandra Medical College and Research Institute, SRIHER, Porur, Chennai, Tamil Nadu
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Ayub II, Thangaswamy D, Krishna V, Sridharan KS. Role for positron emission tomography-computed tomography in melioidosis. Indian J Nucl Med 2021;36:354-6
|How to cite this URL:|
Ayub II, Thangaswamy D, Krishna V, Sridharan KS. Role for positron emission tomography-computed tomography in melioidosis. Indian J Nucl Med [serial online] 2021 [cited 2021 Dec 4];36:354-6. Available from: https://www.ijnm.in/text.asp?2021/36/3/354/326567
We read with interest the case series, “18-Fluorine-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (PET-CT) in the Evaluation of the Great Masquerader Melioidosis: A Case Series,” by Kulkarni et al., published in the July–September issue of Indian Journal of Nuclear Medicine. The authors have discussed the diagnostic utility of PET-CT in two patients with pyrexia of unknown origin (PUO), an indication for which PET-CT has been discussed in previously published literature.,, The two patients were subsequently diagnosed with melioidosis. The authors have performed PET-CT before achieving a diagnosis of melioidosis, rather than part of evaluation of proven melioidosis, as the title suggests. However, we believe that the authors have raised an interesting point and led us to consider and propose PET-CT as an ideal investigation in the evaluation of proven melioidosis, with the illustration of a patient who recently presented to us.
A 34-year-old male with no significant history presented with 5 days of fever, cough, purulent sputum, and dyspnea. He had fever, tachycardia, tachypnea with room air peripheral saturation of 92%, and bilateral basilar crackles on chest auscultation. Abdominal and neurological examination was normal. Apart from anemia and leukocytosis, the blood hematology and biochemistry were normal. Serology for human immunodeficiency virus and scrub typhus were negative. Peripheral smear did not reveal malarial parasites. Chest radiograph [Figure 1]a showed bilateral lung nodules. He was diagnosed with community-acquired pneumonia, and after sending sputum and blood cultures, he was initiated on intravenous (IV) ceftriaxone and admitted in the ward. His sputum and blood culture [Figure 1]b and [Figure 1]c confirmed Burkholderia pseudomallei, following which he was switched to IV ceftazidime. PET-CT was performed, which showed bilateral lung nodules with mild FDG uptake, some with feeding vessel sign, and mediastinal lymphadenopathy, with no evidence of uptake elsewhere [Figure 1]d. He improved clinically with 2 weeks of IV ceftazidime and was discharged on oral cotrimoxazole for 3 months. Chest radiograph 3 months later showed complete resolution [Figure 1]e.
|Figure 1: (a) Chest radiograph showing bilateral lung nodules. (b) Gram stain of sputum sample showing Gram-negative rods with beaded ends. (c) Blood culture on MacConkey agar at 72 h of incubation showing colonies with dry, wrinkled, and metallic sheen appearance suggestive of Burkholderia pseudomallei. (d) Positron-emission tomography-computed tomography scan of thorax at the level of bifurcation of main pulmonary artery showing bilateral variable sized random lung nodules, some with feeding vessel sign and mediastinal lymphadenopathy. (e) Chest radiograph after 3 months of eradication therapy|
Click here to view
Although melioidosis commonly presents with pulmonary involvement, it can involve various other organs, including liver, spleen, lymph nodes, bones, joints, skin, and the central nervous system., Treatment of meloidosis consists of a 2–4-week intensive phase to treat bacteremia, followed by an eradication phase to eliminate any residual focus of bacteria. The duration of this eradication phase is determined by extent of multifocal involvement and evidence of deep seated infection. The failure of eradication may lead to a future relapse. Hence, it becomes important to image various organ systems, including abdomen and the axial and appendicular skeleton, to identify disease involvement elsewhere. Such a multimodality imaging approach, which may include an ultrasound of abdomen and magnetic resonance imaging of spine, may be cumbersome and can be replaced by a whole-body (PET-CT) scan, which can additionally detect disease in less common sites.
The use of PET-CT scan in the management of melioidosis is infrequently reported and was reviewed by the authors. [Table 1] summarizes the available literature.,,,, The indications for PET-CT in the reviewed publications were varied and included (1) to identify possible malignancy or metastases in a patient with clinical suspicion of malignancy,,, (2) to look for other sites of organ involvement in a patient with blood culture-proven melioidosis, (3) in the evaluation of PUO and to identify an appropriate diagnostic investigation, and (4) in the follow-up of patients with melioidosis and multiple site involvement to assess response to treatment., Except for three, all the patients reported above had chronic symptoms and were being evaluated for possible malignancy or PUO. Two patients, who had symptoms for 4 days and 2 weeks, respectively, had thoracic radiology that was suspicious for malignancy and hence were subjected to PET-CT., Only in one patient, who had a subacute presentation, PET-CT was done after a positive culture of melioidosis, with the aim of searching for disease involvement in other sites, similar to our indication. We believe that this indication has its benefits in avoiding multiple system-specific imaging, helps identify asymptomatic disease sites that may be responsible for future relapse if left untreated, and thus helps decide on duration of eradication therapy.
|Table 1: Review of previously published literature on positron emission tomography-computed tomography in melioidosis|
Click here to view
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given his consent for his images and other clinical information to be reported in the journal. The patient understands that his name and initials will not be published and due efforts will be made to conceal identity, but anonymity cannot be guaranteed.
We would like to thank Dr. Arunan Murali MD, Professor, Department of Radiology, for his contribution to reporting and interpretation of PET-CT scan.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Kulkarni P, Shelley S, Elangoven IM, Jaykanth A, Ejaz AP, Rao NS. 18-fluorine-fluorodeoxyglucose positron emission tomography-computed tomography in the evaluation of the great masquerader melioidosis: A case series. Indian J Nucl Med 2020;35:222-5. [Full text]
Kan Y, Wang W, Liu J, Yang J, Wang Z. Contribution of 18F-FDG PET/CT in a case-mix of fever of unknown origin and inflammation of unknown origin: A meta-analysis. Acta Radiol 2019;60:716-25.
Bharucha T, Rutherford A, Skeoch S, Alavi A, Brown M, Galloway J. FDG-PET/CT in fever of unknown origin working group. Diagnostic yield of FDG-PET/CT in fever of unknown origin: A systematic review, meta-analysis, and Delphi exercise. Clin Radiol 2017;72:764-71.
Singh N, Kumar R, Malhotra A, Bhalla AS, Kumar U, Sood R. Diagnostic utility of fluorodeoxyglucose positron emission tomography/computed tomography in pyrexia of unknown origin. Indian J Nucl Med 2015;30:204-12.
] [Full text]
Gassiep I, Armstrong M, Norton R. Human melioidosis. Clin Microbiol Rev 2020;33:e00006-19.
Alsaif HS, Venkatesh SK. Melioidosis: Spectrum of radiological manifestations. Saudi J Med Med Sci 2016;4:74-8.
] [Full text]
Sullivan RP, Marshall CS, Anstey NM, Ward L, Currie BJ. 2020 Review and revision of the 2015 Darwin melioidosis treatment guideline; paradigm drift not shift. PLoS Negl Trop Dis 2020;14:e0008659.
Subran B, Ackermann F, Watin-Augouard L, Rammaert B, Rivoisy C, Vilain D, et al.
Melioidosis in a European traveler without comorbidities: A case report and literature review. Int J Infect Dis 2013;17:e781-3.
Conrad A, Valour F, Ferry T, Ader F, Lyon BJI Study Group. Multifocal melioidosis with femoral osteomyelitis in a healthy 25-year-old traveller. BMJ Case Rep. 2016 Jul 18;2016:bcr2016216356.
Zaw KK, Wasgewatta SL, Kwong KK, Fielding D, Heraganahally SS, Currie BJ. Chronic pulmonary melioidosis masquerading as lung malignancy diagnosed by EBUS guided sheath technique. Respir Med Case Rep 2019;28:100894.
Zhao J, Yap A, Wu E, Yap J. A mimic of bronchogenic carcinoma-Pulmonary melioidosis. Respir Med Case Rep 2020;29:101006.